Lipum AB (publ) (STO:LIPUM)
Sweden · Delayed Price · Currency is SEK 14.35
+0.10 (0.70%)
At close: Mar 18, 2026
Lipum AB Market Cap
Lipum AB has a market cap or net worth of 304.4 million as of March 20, 2026. Its market cap has decreased by -19.38% in one year.
Market Cap
304.40M
Enterprise Value
302.84M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
14.35
Market Cap Chart
Since April 22, 2021, Lipum AB's market cap has increased from 114.77M to 304.40M, an increase of 165.23%. That is a compound annual growth rate of 21.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 304.40M | -1.71% |
| Dec 30, 2025 | 309.70M | 21.67% |
| Dec 30, 2024 | 254.55M | 319.14% |
| Dec 29, 2023 | 60.73M | -43.12% |
| Dec 30, 2022 | 106.78M | 14.23% |
| Dec 30, 2021 | 93.47M | -18.56% |
| Apr 22, 2021 | 114.77M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oncopeptides AB | 461.42M |
| Ascelia Pharma AB | 391.39M |
| Corline Biomedical AB | 386.76M |
| Bio-Works Technologies AB | 319.15M |
| Elicera Therapeutics AB | 257.24M |
| Mendus AB | 254.29M |
| Intervacc AB | 252.20M |
| Sprint Bioscience AB | 224.75M |